
Accomplished Clinical Development Biostatistician with a PhD in Statistics and extensive experience leading Phase I and III oncology and immunology studies. Delivers statistical leadership through innovative trial design, adaptive methodologies, and regulatory strategy. Collaborates with cross-functional teams to translate complex quantitative findings into actionable strategies and informed decisions, ensuring high-quality outputs aligned with ICH-GCP standards.